Related Experiment Video
Updated: Apr 9, 2026

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
Potential correlation between chronic pain and amyloid beta in Alzheimer's disease
1Department of Basic Medicine, School of Medicine, Qingdao Huanghai University, Qingdao, China.
None:
Pain refers to an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Chronic pain is a common symptom among Alzheimer's disease (AD) patients. Due to the cognitive impairment characteristic of mid-to-late-stage AD, many AD patients fail to receive timely pain relief, leading to worsening of the disease. Understanding the relationship between chronic pain and the pathological progression of AD is crucial. Previous studies have confirmed a close correlation between pain occurrence and the metabolism of amyloid beta (Aβ) protein, one of the hallmark pathological features of AD. This article provides an overview of recent research progress on the interaction between pain and Aβ, analyzes its molecular mechanisms, and offers new research insights for effectively alleviating pain in AD patients and preventing or treating AD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils

